Patents by Inventor Elisabeth Torunn Tjelle

Elisabeth Torunn Tjelle has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Device and method for single-needle in vivo electroporation
    Patent number: 11331479
    Abstract: Described is a device and method for administration of molecules to tissue in vivo for various medical applications, the device comprising a single hypodermic injection needle and at least two spaced elongate electrodes which provide for the ability, when the needle is inserted into tissue, such as skin or muscle, to pulse tissue with a non-uniform electric field sufficient to cause reversible poration of cells lying along or in close proximity to the track made by the needle upon its insertion into said tissue.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: May 17, 2022
    Assignee: Inovio Pharmaceuticals, Inc.
    Inventors: Rune Kjeken, Iacob Mathiesen, Elisabeth Torunn Tjelle, George McHugh
  • DEVICE AND METHOD FOR SINGLE-NEEDLE IN VIVO ELECTROPORATION
    Publication number: 20200001076
    Abstract: Described is a device and method for administration of molecules to tissue in vivo for various medical applications, the device comprising a single hypodermic injection needle and at least two spaced elongate electrodes which provide for the ability, when the needle is inserted into tissue, such as skin or muscle, to pulse tissue with a non-uniform electric field sufficient to cause reversible poration of cells lying along or in close proximity to the track made by the needle upon its insertion into said tissue.
    Type: Application
    Filed: July 9, 2019
    Publication date: January 2, 2020
    Inventors: Rune KJEKEN, Iacob MATHIESEN, Elisabeth Torunn TJELLE, George McHUGH
  • Device and method for single-needle in vivo electroporation
    Patent number: 10369359
    Abstract: Described is a device and method for administration of molecules to tissue in vivo for various medical applications, the device comprising a single hypodermic injection needle and at least two spaced elongate electrodes which provide for the ability, when the needle is inserted into tissue, such as skin or muscle, to pulse tissue with a non-uniform electric field sufficient to cause reversible poration of cells lying along or in close proximity to the track made by the needle upon its insertion into said tissue.
    Type: Grant
    Filed: February 9, 2007
    Date of Patent: August 6, 2019
    Assignee: Genetronics, Inc.
    Inventors: Rune Kjeken, Iacob Mathiesen, Elisabeth Torunn Tjelle, George McHugh